$21.530
+0.041 (+0.19%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
DAWN 相似圖表分析預測
Alphio's DAWN stock price prediction model matches the current Day One Biopharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.51 (-0.09%). The 1-week path is $21.79 (+1.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Day One Biopharmaceuticals Inc 股票嗎？
Day One Biopharmaceuticals Inc (DAWN) is not a good buy for a beginner, long-term investor at this time. The stock is being acquired by Servier at a fixed price of $21.50 per share, which limits any upside potential. The acquisition has already been finalized, and the stock price is trading at the acquisition price, leaving no room for growth or significant returns.
DAWN 股價於 Wednesday 收在 $21.53，此前上漲 +0.19%
Day One Biopharmaceuticals Inc (DAWN) last closed at $21.53, gaining +0.19%. These facts feed the 1-day and 1-week DAWN price prediction above.
預測驅動因素
Day One Biopharmaceuticals Inc（DAWN）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 DAWN 最接近的股票，依相似度排序。
DAWN 季節性分析
Historically the probability of a positive August return for DAWN is 0.00%. February offers the highest probability of a positive month at 65.52%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。